Q2 2021 13F Holders as of 30 Jun 2021
-
Type / Class
-
Equity / Common Shares, no par value
-
Shares outstanding
-
30,767,343
-
Total 13F shares
-
4,022,892
-
Share change
-
-285,620
-
Total reported value
-
$66,543,749
-
Put/Call ratio
-
228%
-
Price per share
-
$16.56
-
Number of holders
-
55
-
Value change
-
-$4,616,131
-
Number of buys
-
20
-
Number of sells
-
35
Institutional Holders of XBiotech Inc. - Common Shares, no par value (XBIT) as of Q2 2021
As of 30 Jun 2021,
XBiotech Inc. - Common Shares, no par value (XBIT) was held by
55 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
4,022,892 shares.
The largest 10 holders included
BlackRock Inc., VANGUARD GROUP INC, STATE STREET CORP, GEODE CAPITAL MANAGEMENT, LLC, NORTHERN TRUST CORP, WELLS FARGO & COMPANY/MN, CREDIT SUISSE AG/, Bank of New York Mellon Corp, Swiss National Bank, and ALPS ADVISORS INC.
This page lists
55
institutional shareholders reporting positions in this security
for the Q2 2021 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.